Gov’t Alerts Public to Counterfeit Cancer Drug Found in Kenyan Market
In Summary:
The Pharmacy and Poisons Board (PPB) has issued a warning concerning a batch of counterfeit Herceptin 440mg (Trastuzumab 440mg) drugs used in treating breast and stomach cancer, recently discovered in Kenya.
The counterfeit drugs, identified by batch number C5830083, purportedly manufactured by Roche Products Ltd in Germany, have falsified contents, packaging, and labeling, as confirmed by the brand owner. PPB advises against the use, sale, or distribution of this product due to safety concerns.
The Pharmacy and Poisons Board (PPB) has sounded an alarm over the presence of a dubious batch of counterfeit Herceptin 440mg (Trastuzumab 440mg) drugs in the Kenyan market, used for breast and stomach cancer treatment.
According to PPB, the counterfeit drugs, marked with ...